Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus

Control of hyperglycemia and prevention of glucose reabsorption (glucotoxicity) are important objectives in the management of type 2 diabetes. This study deals with an oral combined dosage form design for two anti-diabetic drugs, sitagliptin and dapagliflozin using self-nanoemulsifying drug delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazi, Mohsin, Alqahtani, Abdulmohsen, Ahmad, Ajaz, Noman, Omar M., Aldughaim, Mohammed S., Alqahtani, Ali S., Alanazi, Fars K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875557/
https://www.ncbi.nlm.nih.gov/pubmed/33345632
http://dx.doi.org/10.1080/10717544.2020.1859001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875557/
https://www.ncbi.nlm.nih.gov/pubmed/33345632
http://dx.doi.org/10.1080/10717544.2020.1859001

Ejemplares similares